A client has just been diagnosed as having major depression. At which time would the nurse expect the client to be at highest risk for self- harm?

The highest risk for self-harm in a patient with major depression often occurs when their energy levels begin to improve while their depressed mood remains. This clinical phenomenon is frequently observed approximately 2 weeks after the initiation of antidepressant therapy (such as SSRIs). During this window, the patient gains the physical energy and cognitive focus required to formulate and execute a suicide plan, whereas previously they were too lethargic or paralyzed by their depression to act on such thoughts. Rationale: A. Family visits can be emotionally taxing or trigger feelings of guilt, but they do not statistically correlate with a peak in suicide risk as strongly as the physiological shift seen during the early stages of pharmacotherapy. In some cases, family visits can actually provide a temporary protective effect through social connection. B. This is a critical safety period known as the window of vulnerability. Antidepressants typically improve physical symptoms (sleep, appetite, energy) before they improve the psychological symptoms of hopelessness. The nurse must increase monitoring and perform frequent lethality assessments during this time to ensure the patient's newfound energy is not used for self-destruction. C. During the first few days of admission, the patient is often in a controlled, highly supervised environment where access to lethal means is restricted. Furthermore, the acute phase of depression usually involves severe psychomotor retardation, which physically limits the patient's ability to carry out complex actions. D. Anniversaries of significant life events such as the death of a loved one or a divorce are known triggers for increased depressive symptoms and suicidal ideation. However, in the context of clinical treatment, the most predictable and dangerous physiological risk factor remains the rebound in energy following the start of medication.